These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 17545690)

  • 1. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
    Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
    JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
    Hansford S; Kaurah P; Li-Chang H; Woo M; Senz J; Pinheiro H; Schrader KA; Schaeffer DF; Shumansky K; Zogopoulos G; Santos TA; Claro I; Carvalho J; Nielsen C; Padilla S; Lum A; Talhouk A; Baker-Lange K; Richardson S; Lewis I; Lindor NM; Pennell E; MacMillan A; Fernandez B; Keller G; Lynch H; Shah SP; Guilford P; Gallinger S; Corso G; Roviello F; Caldas C; Oliveira C; Pharoah PD; Huntsman DG
    JAMA Oncol; 2015 Apr; 1(1):23-32. PubMed ID: 26182300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.
    Suriano G; Yew S; Ferreira P; Senz J; Kaurah P; Ford JM; Longacre TA; Norton JA; Chun N; Young S; Oliveira MJ; Macgillivray B; Rao A; Sears D; Jackson CE; Boyd J; Yee C; Deters C; Pai GS; Hammond LS; McGivern BJ; Medgyesy D; Sartz D; Arun B; Oelschlager BK; Upton MP; Neufeld-Kaiser W; Silva OE; Donenberg TR; Kooby DA; Sharma S; Jonsson BA; Gronberg H; Gallinger S; Seruca R; Lynch H; Huntsman DG
    Clin Cancer Res; 2005 Aug; 11(15):5401-9. PubMed ID: 16061854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline CDH1 Variants and Lifetime Cancer Risk.
    Ryan CE; Fasaye GA; Gallanis AF; Gamble LA; McClelland PH; Duemler A; Samaranayake SG; Blakely AM; Drogan CM; Kingham K; Patel D; Rodgers-Fouche L; Siegel A; Kupfer SS; Ford JM; Chung DC; Dowty JG; Sampson J; Davis JL
    JAMA; 2024 Sep; 332(9):722-729. PubMed ID: 38873722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families.
    Pharoah PD; Guilford P; Caldas C;
    Gastroenterology; 2001 Dec; 121(6):1348-53. PubMed ID: 11729114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
    Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
    Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
    Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
    Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
    Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
    J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDH1 mutations recurrence and global clustering in genetically tested families with hereditary diffuse gastric cancer syndrome: results from a systematic study.
    Corso G; Tagliaferri V; Massari G; Cioffi A; Rossi EMC; Veronesi P; Magnoni F
    Fam Cancer; 2023 Apr; 22(2):187-192. PubMed ID: 35882702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
    Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
    Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
    Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
    Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
    Humar B; Toro T; Graziano F; Müller H; Dobbie Z; Kwang-Yang H; Eng C; Hampel H; Gilbert D; Winship I; Parry S; Ward R; Findlay M; Christian A; Tucker M; Tucker K; Merriman T; Guilford P
    Hum Mutat; 2002 May; 19(5):518-25. PubMed ID: 11968084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer.
    Pena-Couso L; Perea J; Melo S; Mercadillo F; Figueiredo J; Sanches JM; Sánchez-Ruiz A; Robles L; Seruca R; Urioste M
    Eur J Hum Genet; 2018 Sep; 26(9):1348-1353. PubMed ID: 29769627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of founder and recurrent CDH1 mutations in hereditary diffuse gastric cancer.
    Kangelaris KN; Gruber SB
    JAMA; 2007 Jun; 297(21):2410-1. PubMed ID: 17545691
    [No Abstract]   [Full Text] [Related]  

  • 19. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
    Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
    JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.
    van der Post RS; Vogelaar IP; Carneiro F; Guilford P; Huntsman D; Hoogerbrugge N; Caldas C; Schreiber KE; Hardwick RH; Ausems MG; Bardram L; Benusiglio PR; Bisseling TM; Blair V; Bleiker E; Boussioutas A; Cats A; Coit D; DeGregorio L; Figueiredo J; Ford JM; Heijkoop E; Hermens R; Humar B; Kaurah P; Keller G; Lai J; Ligtenberg MJ; O'Donovan M; Oliveira C; Pinheiro H; Ragunath K; Rasenberg E; Richardson S; Roviello F; Schackert H; Seruca R; Taylor A; Ter Huurne A; Tischkowitz M; Joe ST; van Dijck B; van Grieken NC; van Hillegersberg R; van Sandick JW; Vehof R; van Krieken JH; Fitzgerald RC
    J Med Genet; 2015 Jun; 52(6):361-74. PubMed ID: 25979631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.